ESC Congress 2024
Showcasing a plethora of novel data and science presented by the world’s leading cardiology experts at ESC Congress 2024, taking place August 30-September 2 in London, England.
An AI-enabled stethoscope can help physicians identify twice as many cases of heart failure compared to usual obstetric care.
The EPIC-CAD trial addresses a crucial question in managing patients with both atrial fibrillation and stable CAD.
The SCOFF trial challenges the long-standing practice of fasting before cardiac catheterization procedures.
PVI results in clinically important improvements in both symptom burden and quality of life compared with a placebo.
The NOTION 3 trial contributes important data to the ongoing debate about the role of PCI before TAVI in patients with CAD.
A single-pill combination of four BP-lowering medications is more effective than a combination of three therapies.
People that 'catch up' on their sleep during the weekends have a considerably lower risk of heart disease.
Clinical follow-up using AI-generated technology can help identify complications in patients following TAVI.
Advertisement
Advertisement